Patricia Diana Sørensen

Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer

Ann Christina Pedersen, Patricia Diana Sørensen, E.H. Jacobsen et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2013 · 67 citations

Home Management of Oral Anticoagulation via Telemedicine Versus Conventional Hospital-Based Treatment

Henry Christensen, Jens-Jacob Lauterlein, Patricia Diana Sørensen et al. · Telemedicine Journal and e-Health · 2011 · 46 citations · Full text

Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting

Patricia Diana Sørensen, Erik Jakobsen, Sven Tyge Langkjer et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2009 · 26 citations · Full text

Serum HER-2 predicts response and resistance to trastuzumab treatment in breast cancer

Eva Rabing Brix Petersen, Patricia Diana Sørensen, Erik Jakobsen et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2013 · 20 citations

Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients

Patricia Diana Sørensen, Erik Jakobsen, Jonna Skov Madsen et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 17 citations · Full text

Serum Her-2, Breast Oncology, Breast Cancer Patients +7